The Reserve Bank of India’s recent currency market curbs aimed at quelling speculation against the rupee are temporary and will not remain in place forever, Governor Sanjay Malhotra said. Arbitrage ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of the Food and Drug Administration headquarters in White Oak, Maryland, U.S., August 29, 2020 ...

Weight-loss company Noom has acquired 503A pharmacy Tailor Made Compounding, which Noom said will allow it to expand its behavior change programs and move beyond weight health. Tailor Made provides ...

The U.S. FDA appears poised to allow compounding pharmacies to again sell injectable peptides, a class of products with questionable anti-aging and anti-disease benefits that came under scrutiny for ...

The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell. By Christina ...

India’s central bank stepped up its defense of the battered rupee, rolling out a measure to curb speculation after it slid to a new low amid concerns of a widening trade gap driven by the US-Iran war.

The finance ministers of Japan and South Korea on Saturday said that they are willing to take appropriate steps to defend their respective currencies, which have sharply depreciated against the U.S.

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. as drugmakers and the FDA alike seek to crack down on the ...

China’s foreign-exchange reserves edged up in February, as policymakers keep a wary eye on the spillover effect of the war in Iran on global financial markets. According to official data released ...

You’ve probably seen compounding making headlines recently, and not for the right reasons. From so-called “personalized” GLP-1s flooding the market to telehealth startups touting hormone “rebalancing” ...

The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...